Conference attendees told ISIS-3 shows equal efficacy, safety differences among thrombolytics.
Check
W A
WA
D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents; D001241:Aspirin